259 related articles for article (PubMed ID: 30663443)
1. Psoriasis-associated itch: etiology, assessment, impact, and management.
Pithadia DJ; Reynolds KA; Lee EB; Wu JJ
J Dermatolog Treat; 2020 Feb; 31(1):18-26. PubMed ID: 30663443
[TBL] [Abstract][Full Text] [Related]
2. Current and Emerging Therapies for Itch Management in Psoriasis.
Stull C; Grossman S; Yosipovitch G
Am J Clin Dermatol; 2016 Dec; 17(6):617-624. PubMed ID: 27460912
[TBL] [Abstract][Full Text] [Related]
3. Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam.
Jalili A; Lebwohl M; Stein Gold L; Andersen SB; Jensen KL; Pink AE; Segaert S; Berg P; Calzavara-Pinton PG; de la Cueva Dobao P; Thaçi D
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):709-717. PubMed ID: 30520168
[TBL] [Abstract][Full Text] [Related]
4. Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
Bagel J; Levi E; Tyring S; Knuckles ML
J Drugs Dermatol; 2014 Nov; 13(11):1374-9. PubMed ID: 25607705
[TBL] [Abstract][Full Text] [Related]
5. Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris.
Kontochristopoulos G; Kouris A; Chantzaras A; Petridis A; Yfantopoulos J
An Bras Dermatol; 2016 Apr; 91(2):160-6. PubMed ID: 27192514
[TBL] [Abstract][Full Text] [Related]
6. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Systemic Treatments of Psoriasis on Pruritus: A Systemic Literature Review and Meta-Analysis.
Théréné C; Brenaut E; Barnetche T; Misery L
J Invest Dermatol; 2018 Jan; 138(1):38-45. PubMed ID: 28887107
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Mechanisms of Itch in Psoriasis.
Komiya E; Tominaga M; Kamata Y; Suga Y; Takamori K
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182442
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.
Gallo L; Megna M; Cirillo T; Caterino P; Lodi G; Mozzillo R; Dente V; Balato A
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1312-1315. PubMed ID: 30767288
[TBL] [Abstract][Full Text] [Related]
10. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.
Griffiths CE; Stein Gold L; Cambazard F; Kalb RE; Lowson D; Møller A; Paul C
Eur J Dermatol; 2018 Jun; 28(3):356-363. PubMed ID: 29952297
[TBL] [Abstract][Full Text] [Related]
11. Itch in Psoriasis Management.
Szepietowski JC; Reich A
Curr Probl Dermatol; 2016; 50():102-10. PubMed ID: 27578078
[TBL] [Abstract][Full Text] [Related]
12. Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.
Kimball AB; Luger T; Gottlieb A; Puig L; Kaufmann R; Nikaï E; Zhu B; Edson-Heredia E; Carlier H; Lin CY; Goldblum O; Yosipovitch G
J Am Acad Dermatol; 2016 Dec; 75(6):1156-1161. PubMed ID: 27692498
[TBL] [Abstract][Full Text] [Related]
13. Assessment of pruritus in patients with psoriasis and atopic dermatitis: subjective and objective tools.
Price A; Cohen DE
Dermatitis; 2014; 25(6):334-44. PubMed ID: 25384221
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
Kimball AB; Naegeli AN; Edson-Heredia E; Lin CY; Gaich C; Nikaï E; Wyrwich K; Yosipovitch G
Br J Dermatol; 2016 Jul; 175(1):157-62. PubMed ID: 26852717
[TBL] [Abstract][Full Text] [Related]
15. Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States.
Wu JJ; Veverka KA; Lu M; Armstrong AW
J Dermatolog Treat; 2019 Aug; 30(5):454-460. PubMed ID: 30307343
[No Abstract] [Full Text] [Related]
16. Treating itch in psoriasis.
Dawn A; Yosipovitch G
Dermatol Nurs; 2006 Jun; 18(3):227-33. PubMed ID: 16856675
[TBL] [Abstract][Full Text] [Related]
17. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.
Steinke S; Zeidler C; Riepe C; Bruland P; Soto-Rey I; Storck M; Augustin M; Bobko S; Garcovich S; Legat FJ; Lvov A; Misery L; Osada N; Reich A; Şavk E; Serra-Baldrich E; Streit M; Szepietowski JC; Weger W; Dugas M; Ständer S
J Am Acad Dermatol; 2018 Sep; 79(3):457-463.e5. PubMed ID: 30119869
[TBL] [Abstract][Full Text] [Related]
18. Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.
Frieder J; Kivelevitch D; Menter A
Ther Deliv; 2017 Aug; 8(9):737-746. PubMed ID: 28659016
[TBL] [Abstract][Full Text] [Related]
19. Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.
Wang Y; Coyne K; Sofen H; Santanello N; Currie B; Zhang Z; Nograles K
J Dermatolog Treat; 2019 Dec; 30(8):775-783. PubMed ID: 30747550
[No Abstract] [Full Text] [Related]
20. Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial.
Zhu B; Edson-Heredia E; Guo J; Maeda-Chubachi T; Shen W; Kimball AB
Br J Dermatol; 2014 Nov; 171(5):1215-9. PubMed ID: 24749812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
